Fast and straightforward simultaneous quantification of multiple apolipoproteins in human serum on a high‐throughput LC‐MS/MS platform
Authors:
- 25 December 2022
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 17 (3) , e2200056
Abstract
Purpose: Apolipoprotein monitoring is useful for diagnosing cardiovascular diseases, as they are risk factors of arteriosclerosis and other neutral fat‐related diseases. Liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) is advantageous for simultaneous apolipoprotein quantification, differentiation, and standardization including their isoforms. However, fast and straightforward sample preparation that retains quantification accuracy remains challenging in clinical MS.Experimental Design: We developed a simultaneous assay for serum apolipoprotein A‐I (ApoA‐I), apolipoprotein B100 family, and apolipoprotein C‐III (ApoC‐III) using a high‐throughput LC‐MS/MS platform coupled with a BRAVO system. The assay was simplified by using sodium deoxycholate and trypsin/lys‐C without reduction and alkylation steps.Results: Simple sample preparation reduced turnaround time by 1.5 h and neat goat serum was chosen as an optimal calibration matrix for accurate protein quantification. Assay precision, linearity, correlation, accuracy, limit of detection (LOD), limit of quantitation (LOQ), and carryover were validated according to CLSI guidelines over 41 days using more than 100 human serum samples. Good correlation compared with turbidimetric immunoassay (TIA) was observed by Deming regression for all analytes.Conclusions and Clinical Relevance: A high‐throughput LC‐MS/MS and BRAVO assay for simultaneous apolipoprotein analysis was validated using a simple preparation method with a human serum calibrator in goat serum matrix. The assay is readily expandable to include other target serum proteins and/or their isoforms.Keywords
This publication has 11 references indexed in Scilit:
- Targeted On‐line SPE‐LC‐MS/MS Assay for the Quantitation of 12 Apolipoproteins from Human BloodProteomics, 2018
- High throughput quantification of apolipoproteins A‐I and B‐100 by isotope dilution MS targeting fast trypsin releasable peptides without reduction and alkylationProteomics – Clinical Applications, 2017
- Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E PhenotypingClinical Chemistry, 2016
- Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA–MALDI-TOF-MS workflowMethods, 2015
- Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MSJournal of Lipid Research, 2014
- Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC‐MS/MSProteomics – Clinical Applications, 2013
- Large-Scale Quantitative Assessment of Different In-Solution Protein Digestion Protocols Reveals Superior Cleavage Efficiency of Tandem Lys-C/Trypsin Proteolysis over Trypsin DigestionJournal of Proteome Research, 2012
- A rapid method for cross‐species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra‐performance liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2011
- Simultaneous Quantification of Apolipoprotein A-I and Apolipoprotein B by Liquid-Chromatography–Multiple- Reaction–Monitoring Mass SpectrometryClinical Chemistry, 2010
- Lipoprotein disorders and cardiovascular riskJournal of Inherited Metabolic Disease, 2003